제약·바이오업계기상도
삼성바이오로직스, ‘맑음’ CDMO 모달리티 확장 본격화…명문제약, ‘흐림’ 주요 임원진 주식 매수
(서울=NSP통신) jeonghyun go Journal = CJ CGV announced that its operating profit on a consolidated basis in fourth quater 2018 dropped 40 percent to 25.61 billion won compared to 2017.
Sales decreased to around 450.4 billion won by 1 percent in the same period.
NSP News Agency/NSP TV jeonghyun go Journalist, gojh89@nspna.com
Copyright ⓒ Korea's economic news agency NSP NEWS·NSP TV. All rights reserved-Redistribution Prohibited.